Guidance

JCVI interim position statement on the use of Bexsero meningococcal B vaccine in the UK

An interim position statement about the use of Bexsero meningococcal B vaccine in the UK released by JCVI.

• From: Department of Health and Social Care
• Published: 24 July 2013

Applies to England

Documents

JCVI interim position statement on use of Bexsero meningococcal B vaccine in the UK

PDF, 177 KB, 8 pages

Details

The Joint Committee on Vaccination and Immunisation (JCVI) interim position statement sets out the outcome of the considerations of JCVI and its meningococcal sub-committee on the use of meningococcal B vaccine, Bexsero in the UK. JCVI is seeking comments from stakeholders who provided evidence to JCVI and its sub-committee before finalising its position statement.

Published 24 July 2013